Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction-staged sentinel lymph nodes from melanoma patients

Journal of Clinical Oncology

Volumn 22, Issue 19, 2004, Pages 3989-3996

  Kammula, Udai S ^a   Ghossein, Ronald ^a   Bhattacharya, Satyajit ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PARAFFIN; RNA; TUMOR MARKER;

ARTICLE; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY; SKIN TUMOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 5444248733     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.03.052     Document Type: Article

References (27)

1. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001
2. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
3. Gershenwald JE, Thompson W, Mansfield PF, et al: Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17:976-983, 1999
4. Cochran AJ, Wen DR, Herschman HR: Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer 34:159-163, 1984
5. Messina JL, Glass LF, Cruse CW, et al: Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 23:686-690, 1999
6. Yu LL, Flotte TJ, Tanabe KK, et al: Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86:617-627, 1999
7. Gershenwald JE, Colome MI, Lee JE, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998
8. Gadd MA, Cosimi AB, Yu J, et al: Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134:381-387, 1999
9. Essner R, Conforti A, Kelley MC, et al: Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6:442-449, 1999
10. Clary BM, Brady MS, Lewis JJ, et al: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 233: 250-258, 2001
11. Goydos JS, Ravikumar TS, Germino FJ, et al: Minimally invasive staging of patients with melanoma: Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 187:182-188, 1998
12. Wang X, Heller R, VanVoorhis N, et al: Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220:768-774, 1994
13. Sarantou T, Chi DD, Garrison DA, et al: Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res 57:1371-1376, 1997
14. Bieligk SC, Ghossein R, Bhattacharya S, et al: Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol 6:232-240, 1999
15. Blaheta HJ, Schittek B, Breuninger H, et al: Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 23:822-828, 1999
16. Shivers SC, Wang X, Li W, et al: Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA 280:1410-1415, 1998
17. Bostick PJ, Morton DL, Turner RR, et al: Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 17: 3238-3244, 1999
18. Blaheta HJ, Ellwanger U, Schittek B, et al: Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol 114:637-642, 2000
19. 18A. Li W, Stall A, Shivers SC, et al: Clinical relevance of molecular staging for melanoma: Comparison of RT-PCR and immunohistochemistry staining in sentimel lymph nodes of patients with melanoma. Ann Surg 231:795-803, 2000
20. Goydos JS, Patel KN, Shih WJ, et al: Patterns of recurrence in patients with melanoma and histologically negative but RT-PCR-positive sentinel lymph nodes. J Am Coll Surg 196:196-204, 2003
21. Ribuffo D, Gradilone A, Vonella M, et al: Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol 10:396-402, 2003
22. Ghossein RA, Nissan A, Stojadinovic A, et al: Prognostic value of tyrosinase mRNA reverse transcription-polymerase chain reaction in the evaluation of melanoma sentinel lymph nodes. Presented at 37th Annual Meeting of Am Soc Clin Oncol. San Francisco, CA, May 12-15, 2001
23. Ghossein RA, Coit D, Brennan M, et al: Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 4:419-428, 1998
24. Smith B, Selby P, Southgate J, et al: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338:1227-1229, 1991
25. Ben-Ezra J, Johnson DA, Rossi J, et al: Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem 39:351-354, 1991
26. McCarthy WH, Shaw HM, Thompson JF, et al: Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 166:497-502, 1988
27. Taback B, Morton DL, O'Day SJ, et al: The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma. Recent Results Cancer Res 158:78-92, 2001